Do Hyoung Lim

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

Jung Hun Kang, Soon Il Lee, Do Hyoung Lim et al. · Journal of Clinical Oncology · 2012 · 660 citations

Impact of <i>KRAS</i> Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy

Seung Tae Kim, Do Hyoung Lim, Kee‐Taek Jang et al. · Molecular Cancer Therapeutics · 2011 · 141 citations

Kras Mutations, Tumor Biology, First-line Gemcitabine-based Chemotherapy +15

Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma

Jun Ho Yi, Seong Yoon Yi, Hyeran Lee et al. · Melanoma Research · 2011 · 71 citations

Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma

Hyo Song Kim, Kyung‐Hee Kim, Kyoung Ha Kim et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 68 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Epstein-barr Virus +13

Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study

Hyo Song Kim, Eun Kyoung Kim, Hyun Jung Jun et al. · BMC Cancer · 2010 · 64 citations · Full text